Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Macular Degeneration Drug Pipeline Market Status and Forecast (2016-2027)
1.3.2 Global Macular Degeneration Drug Pipeline Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Macular Degeneration Drug Pipeline Supply by Company
2.1 Global Macular Degeneration Drug Pipeline Sales Value by Company
2.2 Macular Degeneration Drug Pipeline Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Macular Degeneration Drug Pipeline Market Status by Type
3.1 Macular Degeneration Drug Pipeline Type Introduction
3.1.1 Gene therapy
3.1.2 Small molecules
3.1.3 Stem cell therapy
3.1.4 Gene therapies
3.2 Global Macular Degeneration Drug Pipeline Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Macular Degeneration Drug Pipeline Market Status by Application
4.1 Macular Degeneration Drug Pipeline Segment by Application
4.1.1 Hospital
4.1.2 Research Institute
4.1.3 Commercial
4.1.4 Other
4.2 Global Macular Degeneration Drug Pipeline Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Macular Degeneration Drug Pipeline Market Status by Region
5.1 Global Macular Degeneration Drug Pipeline Market by Region
5.2 North America Macular Degeneration Drug Pipeline Market Status
5.3 Europe Macular Degeneration Drug Pipeline Market Status
5.4 Asia Pacific Macular Degeneration Drug Pipeline Market Status
5.5 Central & South America Macular Degeneration Drug Pipeline Market Status
5.6 Middle East & Africa Macular Degeneration Drug Pipeline Market Status
6 North America Macular Degeneration Drug Pipeline Market Status
6.1 North America Macular Degeneration Drug Pipeline Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Macular Degeneration Drug Pipeline Market Status
7.1 Europe Macular Degeneration Drug Pipeline Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Macular Degeneration Drug Pipeline Market Status
8.1 Asia Pacific Macular Degeneration Drug Pipeline Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Macular Degeneration Drug Pipeline Market Status
9.1 Central & South America Macular Degeneration Drug Pipeline Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Macular Degeneration Drug Pipeline Market Status
10.1 Middle East & Africa Macular Degeneration Drug Pipeline Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Macular Degeneration Drug Pipeline Market Forecast by Type and by Application
12.1 Global Macular Degeneration Drug Pipeline Sales Value Forecast (2022-2027)
12.2 Global Macular Degeneration Drug Pipeline Forecast by Type
12.3 Global Macular Degeneration Drug Pipeline Forecast by Application
13 Global Macular Degeneration Drug Pipeline Market Forecast by Region/Country
13.1 Global Macular Degeneration Drug Pipeline Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Sinocelltech
14.1.1 Company Information
14.1.2 Macular Degeneration Drug Pipeline Product Introduction
14.1.3 Sinocelltech Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Shanghai Henlius Biotech
14.2.1 Company Information
14.2.2 Macular Degeneration Drug Pipeline Product Introduction
14.2.3 Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Roche
14.3.1 Company Information
14.3.2 Macular Degeneration Drug Pipeline Product Introduction
14.3.3 Roche Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Ribomic
14.4.1 Company Information
14.4.2 Macular Degeneration Drug Pipeline Product Introduction
14.4.3 Ribomic Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 RemeGen
14.5.1 Company Information
14.5.2 Macular Degeneration Drug Pipeline Product Introduction
14.5.3 RemeGen Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Outlook Therapeutics
14.6.1 Company Information
14.6.2 Macular Degeneration Drug Pipeline Product Introduction
14.6.3 Outlook Therapeutics Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Lineage Cell Therapeutics
14.7.1 Company Information
14.7.2 Macular Degeneration Drug Pipeline Product Introduction
14.7.3 Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Kyowa Kirin
14.8.1 Company Information
14.8.2 Macular Degeneration Drug Pipeline Product Introduction
14.8.3 Kyowa Kirin Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Kodiak Sciences
14.9.1 Company Information
14.9.2 Macular Degeneration Drug Pipeline Product Introduction
14.9.3 Kodiak Sciences Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 IVERIC Bio
14.10.1 Company Information
14.10.2 Macular Degeneration Drug Pipeline Product Introduction
14.10.3 IVERIC Bio Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Grifols, S.A.
14.12 Graybug Vision
14.13 EyePoint Pharmaceutical
14.14 CHABiotech
14.15 Bio-Thera Solutions
14.16 Bioeq AG
14.17 AsclepiX Therapeutics
14.18 Amgen
14.19 Alteogen
14.20 Adverum Biotechnologies
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Macular Degeneration Drug Pipeline Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Macular Degeneration Drug Pipeline Sales Value (Million USD) by Company (2019-2021)
Table Global Macular Degeneration Drug Pipeline Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Macular Degeneration Drug Pipeline Sales Area
Table Macular Degeneration Drug Pipeline Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Macular Degeneration Drug Pipeline Sales Value (Million USD) by Type (2016-2021)
Table Global Macular Degeneration Drug Pipeline Sals Value Market Share by Type (2016-2021)
Table North America Macular Degeneration Drug Pipeline Sales Value (Million USD) by Type (2016-2021)
Table North America Macular Degeneration Drug Pipeline Sales Value Market Share by Type (2016-2021)
Table Europe Macular Degeneration Drug Pipeline Sales Value (Million USD) by Type (2016-2021)
Table Europe Macular Degeneration Drug Pipeline Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Macular Degeneration Drug Pipeline Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Macular Degeneration Drug Pipeline Sales Value Market Share by Type (2016-2021)
Table Central & South America Macular Degeneration Drug Pipeline Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Macular Degeneration Drug Pipeline Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Macular Degeneration Drug Pipeline Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Macular Degeneration Drug Pipeline Sales Value Market Share by Type (2016-2021)
Table Global Macular Degeneration Drug Pipeline Sales Value (Million USD) by Application (2016-2021)
Table Global Macular Degeneration Drug Pipeline Value Market Share by Application (2016-2021)
Table North America Macular Degeneration Drug Pipeline Sales Value (Million USD) by Application (2016-2021)
Table North America Macular Degeneration Drug Pipeline Sales Value Market Share by Application (2016-2021)
Table Europe Macular Degeneration Drug Pipeline Sales Value (Million USD) by Application (2016-2021)
Table Europe Macular Degeneration Drug Pipeline Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Macular Degeneration Drug Pipeline Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Macular Degeneration Drug Pipeline Sales Value Market Share by Application (2016-2021)
Table Central & South America Macular Degeneration Drug Pipeline Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Macular Degeneration Drug Pipeline Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Macular Degeneration Drug Pipeline Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Macular Degeneration Drug Pipeline Sales Value Market Share by Application (2016-2021)
Table Global Macular Degeneration Drug Pipeline Sales Value (Million USD) by Region (2016-2021)
Table Global Macular Degeneration Drug Pipeline Value Market Share by Region (2016-2021)
Table North America Macular Degeneration Drug Pipeline Sales Value (Million USD) by Country (2016-2021)
Table North America Macular Degeneration Drug Pipeline Value Market Share by Country (2016-2021)
Table Europe Macular Degeneration Drug Pipeline Sales Value (Million USD) by Country (2016-2021)
Table Europe Macular Degeneration Drug Pipeline Value Market Share by Country (2016-2021)
Table Asia Pacific Macular Degeneration Drug Pipeline Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Macular Degeneration Drug Pipeline Value Market Share by Country (2016-2021)
Table Central & South America Macular Degeneration Drug Pipeline Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Macular Degeneration Drug Pipeline Value Market Share by Country (2016-2021)
Table Middle East & Africa Macular Degeneration Drug Pipeline Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Macular Degeneration Drug Pipeline Value Market Share by Country (2016-2021)
Table Global Macular Degeneration Drug Pipeline Value (Million USD) Forecast by Type (2022-2027)
Table Global Macular Degeneration Drug Pipeline Value Market Share Forecast by Type (2022-2027)
Table Global Macular Degeneration Drug Pipeline Value (Million USD) Forecast by Application (2022-2027)
Table Global Macular Degeneration Drug Pipeline Value Market Share Forecast by Application (2022-2027)
Table Global Macular Degeneration Drug Pipeline Value (Million USD) Forecast by Region (2022-2027)
Table Global Macular Degeneration Drug Pipeline Value Market Share Forecast by Region (2022-2027)
Table Sinocelltech Company Information
Table Sinocelltech Product Introduction
Table Sinocelltech Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
Table Shanghai Henlius Biotech Company Information
Table Shanghai Henlius Biotech Product Introduction
Table Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
Table Roche Company Information
Table Roche Product Introduction
Table Roche Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
Table Ribomic Company Information
Table Ribomic Product Introduction
Table Ribomic Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
Table RemeGen Company Information
Table RemeGen Product Introduction
Table RemeGen Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
Table Outlook Therapeutics Company Information
Table Outlook Therapeutics Product Introduction
Table Outlook Therapeutics Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
Table Lineage Cell Therapeutics Company Information
Table Lineage Cell Therapeutics Product Introduction
Table Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
Table Kyowa Kirin Company Information
Table Kyowa Kirin Product Introduction
Table Kyowa Kirin Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
Table Kodiak Sciences Company Information
Table Kodiak Sciences Product Introduction
Table Kodiak Sciences Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)
Table IVERIC Bio Company Information
Table IVERIC Bio Product Introduction
Table IVERIC Bio Macular Degeneration Drug Pipeline Sales Value, Gross Margin and Global Share (2019-2021)